US20110089095A1 - Separating agent for optical isomers and separation column for optical isomers - Google Patents
Separating agent for optical isomers and separation column for optical isomers Download PDFInfo
- Publication number
- US20110089095A1 US20110089095A1 US12/979,006 US97900610A US2011089095A1 US 20110089095 A1 US20110089095 A1 US 20110089095A1 US 97900610 A US97900610 A US 97900610A US 2011089095 A1 US2011089095 A1 US 2011089095A1
- Authority
- US
- United States
- Prior art keywords
- optical isomers
- inorganic type
- polysaccharide
- type carrier
- monolithic inorganic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000003287 optical effect Effects 0.000 title claims abstract description 95
- 238000000926 separation method Methods 0.000 title claims abstract description 49
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 98
- 239000005017 polysaccharide Substances 0.000 claims abstract description 98
- 239000011148 porous material Substances 0.000 claims abstract description 86
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 30
- 150000004676 glycans Chemical class 0.000 claims abstract 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- AKZWRTCWNXHHFR-PDIZUQLASA-N [(3S)-oxolan-3-yl] N-[(2S,3S)-4-[(5S)-5-benzyl-3-[(2R)-2-carbamoyloxy-2,3-dihydro-1H-inden-1-yl]-4-oxo-3H-pyrrol-5-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate Chemical compound NC(=O)O[C@@H]1Cc2ccccc2C1C1C=N[C@](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCOC2)(Cc2ccccc2)C1=O AKZWRTCWNXHHFR-PDIZUQLASA-N 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 150000004804 polysaccharides Chemical class 0.000 description 92
- 239000002904 solvent Substances 0.000 description 52
- 238000000034 method Methods 0.000 description 28
- 239000000243 solution Substances 0.000 description 24
- 229920000856 Amylose Polymers 0.000 description 17
- 125000000524 functional group Chemical group 0.000 description 17
- 239000000126 substance Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- SBTVLCPCSXMWIQ-UHFFFAOYSA-N (3,5-dimethylphenyl) carbamate Chemical compound CC1=CC(C)=CC(OC(N)=O)=C1 SBTVLCPCSXMWIQ-UHFFFAOYSA-N 0.000 description 10
- 239000007983 Tris buffer Substances 0.000 description 10
- 239000011230 binding agent Substances 0.000 description 10
- 239000012530 fluid Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000011049 filling Methods 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 125000003277 amino group Chemical group 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- -1 polyoxyethylene Polymers 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229920001221 xylan Polymers 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- SZBUJZVUQOCHLJ-UHFFFAOYSA-N CC1=CC=CC(O)=C1C1=C(C)C=CC=C1O Chemical compound CC1=CC=CC(O)=C1C1=C(C)C=CC=C1O SZBUJZVUQOCHLJ-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920002558 Curdlan Polymers 0.000 description 2
- 239000001879 Curdlan Substances 0.000 description 2
- 229920002670 Fructan Polymers 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical compound OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000019316 curdlan Nutrition 0.000 description 2
- 229940078035 curdlan Drugs 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000002459 porosimetry Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000003980 solgel method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 description 1
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
- MJTFENDZXOFBLA-UHFFFAOYSA-N 1,2,3-tritert-butylbenzene Chemical compound CC(C)(C)C1=CC=CC(C(C)(C)C)=C1C(C)(C)C MJTFENDZXOFBLA-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- DZSGDHNHQAJZCO-UHFFFAOYSA-N 1-isocyanato-3,5-dimethylbenzene Chemical compound CC1=CC(C)=CC(N=C=O)=C1 DZSGDHNHQAJZCO-UHFFFAOYSA-N 0.000 description 1
- NOTCQEKRIPQPAW-UHFFFAOYSA-N 3-(2,2,2-trifluoroethoxy)prop-1-ene Chemical compound FC(F)(F)COCC=C NOTCQEKRIPQPAW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 238000004438 BET method Methods 0.000 description 1
- ARCJQKUWGAZPFX-UHFFFAOYSA-N C1=CC=C(C2OC2C2=CC=CC=C2)C=C1 Chemical compound C1=CC=C(C2OC2C2=CC=CC=C2)C=C1 ARCJQKUWGAZPFX-UHFFFAOYSA-N 0.000 description 1
- SXPSZIHEWFTLEQ-UHFFFAOYSA-N CC1=CC=C2C(=C1)CN1CN2CC2=C1C=CC(C)=C2 Chemical compound CC1=CC=C2C(=C1)CN1CN2CC2=C1C=CC(C)=C2 SXPSZIHEWFTLEQ-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- CRZQGDNQQAALAY-UHFFFAOYSA-N Me ester-Phenylacetic acid Natural products COC(=O)CC1=CC=CC=C1 CRZQGDNQQAALAY-UHFFFAOYSA-N 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 108010064983 Ovomucin Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920002305 Schizophyllan Polymers 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- WAPNOHKVXSQRPX-UHFFFAOYSA-N [H]C(C)(O)C1=CC=CC=C1 Chemical compound [H]C(C)(O)C1=CC=CC=C1 WAPNOHKVXSQRPX-UHFFFAOYSA-N 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N [H]C(O)(C(=O)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound [H]C(O)(C(=O)C1=CC=CC=C1)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- ICZHJFWIOPYQCA-UHFFFAOYSA-N [H]C(O)(C1=C2C=CC=CC2=CC2=CC=CC=C21)C(F)(F)F Chemical compound [H]C(O)(C1=C2C=CC=CC2=CC2=CC=CC=C21)C(F)(F)F ICZHJFWIOPYQCA-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003759 ester based solvent Substances 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940052303 ethers for general anesthesia Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002270 exclusion chromatography Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000002243 furanoses Chemical group 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-M phenylacetate Chemical compound [O-]C(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-M 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- 229920005640 poly alpha-1,3-glucan Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 150000003214 pyranose derivatives Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000004808 supercritical fluid chromatography Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/50—Conditioning of the sorbent material or stationary liquid
- G01N30/52—Physical parameters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/29—Chiral phases
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/50—Conditioning of the sorbent material or stationary liquid
- G01N30/52—Physical parameters
- G01N2030/524—Physical parameters structural properties
- G01N2030/528—Monolithic sorbent material
Definitions
- the present invention relates to a separation column for optical isomers, and more particularly to a separation column for optical isomers used for separation of the optical isomers by chromatography.
- the invention relates to a separation column for optical isomers which efficiently separates a broad range of compounds in the separation of pharmaceuticals, foods, agricultural chemicals and perfumes.
- Optical isomers having a relationship of a real image and a mirror image have the same physical and chemical properties such as a boiling point, a melting point, and solubility, but often show differences in interactions for a living matter such as a bioactive including taste and odor.
- a medicine and toxicity there are significant differences in an effect of a medicine and toxicity between the two optical isomers. Therefore, in the Guideline for the Production of Pharmaceuticals, the Ministry of Health, Labor and Welfare describes that “when a drug is a racemic modification, it is desirable to preliminarily study absorption, distribution, metabolism and movement of excretion for each isomer”.
- optical isomers have completely the same physical and chemical properties such as a boiling point, a melting point, and solubility, therefore, each optical isomer could not be separated by classical, ordinary separation means and it was not possible to study on interaction of an individual optical isomer with the living matter.
- energetic studies have been made on techniques for separating optical isomers in order to analyze a wide variety of optical isomers conveniently with high precision.
- an optical resolution method by high performance liquid chromatography in particular an optical resolution method by separation columns for optical isomers for HPLC has progressed.
- a chiral stationary phase composed of an asymmetry recognition agent itself or a chiral stationary phase composed of an asymmetry recognition agent supported on a suitable carrier is used as the separation columns for optical isomers referred to herein.
- asymmetry recognition agent examples include optical active triphenylmethyl polymethacrylate (see e.g., JP 57-150432 A), cellulose, amylose derivatives (see, e.g. , Okamoto Y., Kawashima M., and Hatada K., J. Am. Chem. Soc., 106:5357, 1984), and ovomucoid which is protein (see e.g., JP 63-307829 A).
- a column made up of a monolithic inorganic type porous body (see e.g., JP 6-265534 A) has been known.
- a method of producing such a column made up of an monolithic inorganic type porous body the method of sealing a space between the inorganic type porous body and a column tube by softening plastic or glass with heat has been known (see e.g., JP 2002-505005 A).
- a separation column for optical isomers where cyclodextrin as an asymmetry recognition agent is chemically bound to a monolithic inorganic type porous body has been known (see e.g., JP 2000-515627 A).
- the present invention is a separating agent for optical isomers which is used for separation of optical isomers in a sample comprising the optical isomers, which is comprising a monolithic inorganic type carrier, and at least one of a polysaccharide and a polysaccharide derivative supported on the monolithic inorganic type carrier, wherein: the monolithic inorganic type carrier comprises a porous body in which channels are formed through connection of cavities from one end to the other end of the monolithic inorganic type carrier; the cavities each comprise a macropore and a meso pore formed on an inner wall surface of the macropore; and the meso pore has a pore size of 6 to 100 nm.
- the present invention provides a separation column for optical isomers, comprising: a column tube; and the above-mentioned separating agent for optical isomers which is held in the column tube.
- a monolithic inorganic type carrier having a specific meso pore formed on the inner wall surface of the macropore is used, and at least one of a polysaccharide and a polysaccharide derivative capable of separating optical isomers is supported on the monolithic inorganic type carrier.
- the present invention provides a separating agent for optical isomers having high asymmetry identifying ability and a separation column for optical isomers which can be used in separation, analysis, and fractionation of a wide variety of optical isomers at a high flow rate.
- the separating agent for optical isomers of the invention has a porous monolithic inorganic type carrier and polysaccharide or a derivative thereof supported on this monolithic inorganic type carrier.
- the polysaccharide or the derivative thereof may be directly supported on the monolithic inorganic type carrier, or may be supported through another compound which is appropriate.
- the monolithic inorganic type carrier is generally a cylindrical inorganic type porous body which may be held in a column tube and has a flow path formed through connection of cavities from one end to the other end of the monolithic inorganic type carrier. That is, the monolithic inorganic type carrier is different from a particulate carrier filled in the column tube.
- the monolithic inorganic type carrier preferably contains silica as a major ingredient, but may be comprised of another inorganic material and may contain a small amount of an organic material.
- silica is the major ingredient, it is desirable that surface treatment is given to the monolithic inorganic type carrier in order to exclude an effect of a residual silanol group, but there is no problem even if the surface treatment is not given.
- the monolithic inorganic type carrier may employ a known inorganic type carrier or an improved article thereof.
- Examples thereof include: a porous shaped body described in JP 2000-515627 A; a monolithic adsorbent described in JP 2002-505005 A; and an inorganic porous column described in JP H06-265534 A.
- the monolithic inorganic type carrier can be made by known methods and methods according thereto.
- the monolithic inorganic type carrier can be manufactured by, for example, a sol-gel method where a structure with a solvent rich phase which becomes a huge void is caused by using metal alkoxide as a starting material and adding an appropriate coexisting substance such as a polymer such as polyoxyethylene which dissolves in a solvent to the material as described in JP 7-41374 A.
- the cavities forming the channels each have a macropore and a meso pore formed on an inner surface wall of the macropore.
- a pore size of the macropore may be controlled in accordance with a particle size of the coexisting substance, for example.
- a pore size of the meso pore may be controlled by solidifying a product of the sol-gel method and then immersing the product in an acidic aqueous solution or a basic aqueous solution, for example.
- the macropore is not particularly limited so long as the pore forms channels passing through the monolithic inorganic type carrier along a direction of a flow of a mobile phase when the monolithic inorganic type carrier is provided in a flow path of the mobile phase.
- the channels formed through connecting of the macropores may consist of pores in a straight line or pores continuing in a three dimensional network.
- the channels preferably consists of the pores continuing in a three dimensional network from the viewpoint of improving separation performance.
- a pore size of the macropore may cause difficulties in sufficiently supporting on a monolithic inorganic type carrier a polysaccharide or a polysaccharide derivative for separating optical isomers. Too large a pore size of the macropore may result in insufficient performance of separating optical isomers. From such viewpoints, a pore size of the macropore is preferably 0.5 to 30 ⁇ m, more preferably 0.5 to 10 ⁇ m, futhermore preferably 1.0 to 6.0 ⁇ m, still more preferably 1.0 to 4.5 ⁇ m.
- Too small a pore size of the meso pore may result in:
- a pore size of the meso pore can be increased to a level (several hundred nm) distinguished from that of the macropore.
- a pore size of the meso pore may result in: a reduced effect of surface area expansion by providing the meso pore; a reduced amount of a polysaccharide or a polysaccharide derivative supported on a monolithic inorganic type carrier; and insufficient separation of optical isomers by a polysaccharide or a polysaccharide derivative.
- a pore size of the meso pore is preferably 6 to 100 nm, more preferably 15 to 80 nm, furthermore preferably 20 to 60 nm, and still more preferably 20 to 50 nm.
- the pore size of the macropore can be represented by a value which can represent a substantial pore size of the macropore in the monolithic inorganic type carrier.
- the pore size of the macropore can be represented by the median of the pore size distribution of the macropore in the monolithic inorganic type carrier.
- the pore size distribution of the macropore can be measured by using mercury porosimetry or raster electron microscope.
- the pore size of the meso pore can be represented by a value which can represent a substantial pore size of the meso pore in the monolithic inorganic type carrier.
- the pore size of the meso pore can be represented by the median of the pore size distribution of the meso pore in the monolithic inorganic type carrier.
- the pore size distribution of the meso pore can be measured by using mercury porosimetry, BET method with nitrogen adsorption, or inverse exclusion chromatography (ISEC).
- the monolithic inorganic type carrier has a macropore having a pore size of 0.5 to 10 ⁇ m and a meso pore having a pore size of 15 to 80 nm, preferably a macropore having a pore size of 1.0 to 6.0 ⁇ m and a meso pore having a pore size of 20 to 60 nm, more preferably a macropore having a pore size of 1.0 to 4.5 ⁇ m and a meso pore having a pore size of 20 to 50 nm.
- the polysaccharide may be any of synthetic polysaccharide, naturally occurring polysaccharide and naturally occurring modified polysaccharide, and may be any polysaccharide so long as it is optically active, but those with high regularity of binding manner are preferable, and chain-shaped ones are also preferable.
- polysaccharide examples include: ⁇ -1,4-glucan (cellulose), ⁇ -1,4-glucan (amylose or amylopectin), ⁇ -1,6-glucan (dextran), ⁇ -1,6-glucan (pustulan), ⁇ -1,3-glucan (such as curdlan and schizophyllan), ⁇ -1,3-glucan, ⁇ -1,2-glucan (Crown Gall polysaccharide), ⁇ -1,4-galactan, ⁇ -1,4-mannan, ⁇ -1,6-mannan, ⁇ -1,2-fructan (inulin), ⁇ -2,6-fructan (levan), ⁇ -1,4-xylan, ⁇ -1,3-xylan, ⁇ -1,4-chitosan, ⁇ -1,4-N-acetylchitosan (chitin), pullulan, agarose, and alginic acid. Also, starches containing amylose are included therein.
- those which can be easily obtained as highly pure polysaccharides such as cellulose, amylose, ⁇ -1,4-xylan, ⁇ -1,4-chitosan, chitin, ⁇ -1,4-mannan, inulin, and curdlan, and more preferably cellulose and amylose.
- such a polysaccharide has a number-average degree of polymerization (i.e., the average number of pyranose or furanose rings per molecule) of 5 or more, and more preferably of 10 or more . From the viewpoint of easy handling, it is preferred that the number-average degree of polymerization is 1,000 or less, although the upper limit thereof is not particularly limited. Particularly, it is preferred that a number-average degree of polymerization of polysaccharide is from 50 to 400 in that the polysaccharide or the derivative thereof is supported on the inner wall face of the monolithic inorganic type carrier having meso pores and a sufficient separation effect of the optical isomers is obtained.
- a number-average degree of polymerization i.e., the average number of pyranose or furanose rings per molecule
- the number-average degree of polymerization is 1,000 or less, although the upper limit thereof is not particularly limited.
- a number-average degree of polymerization of polysaccharide is from 50 to 400 in that
- the polysaccharide derivative is not particularly limited so long as it is the polysaccharide derivative which can be used for the separation of optical isomers.
- Such polysaccharide derivatives include, for example, polysaccharide derivatives which contain optical active polysaccharide as a skeleton and where at least a part of a hydroxyl group and an amino group which this polysaccharide has is substituted with a functional group which acts on an optical isomer in a sample.
- the functional group is a functional group which acts on the optical isomer in the sample containing the optical isomers which are subject to the separation. Actions of the functional group for the optical isomer cannot be collectively defined because a type of the functional group is different depending on a type of the optical isomers which are subject to the separation, but they are not particularly limited so long as they are the actions sufficient to perform optical resolution of the optical isomers by the polysaccharide derivatives.
- Such actions include affinitive interactions such as hydrogen bond, ⁇ - ⁇ interaction and dipole-dipole interaction of the optical isomer with the functional group, and non-affinitive interaction such as steric hindrance.
- affinitive interactions such as hydrogen bond, ⁇ - ⁇ interaction and dipole-dipole interaction of the optical isomer with the functional group
- non-affinitive interaction such as steric hindrance.
- the functional group is selected depending on the type of the optical isomers which are subject to the separation.
- the functional groups include groups including aromatic groups which are bound to the polysaccharide, for example via ester bond, urethane bond and ether bond and which may have substituents.
- the aromatic groups include heterocyclic rings and condensed rings. Substituents which the aromatic group may have include, for example, alkyl groups with up to about 8 carbons, halogen, amino groups, and alkoxy groups.
- a degree of substitution of the functional group is not particularly limited.
- the functional group may be substituted with part or all of the hydroxyl groups and amino groups of the polysaccharide, for example.
- the degree of substitution of the functional group is arbitrarily selected depending on various conditions such as a type of the functional group and a type of the polysaccharide.
- a degree of substitution of the functional group is preferably 50 to 100%, more preferably 80 to 100%.
- the degree of substitution of the functional group can be measured through elemental analysis, for example.
- the polysaccharide derivative can be made by known methods.
- the polysaccharide derivative can be made, for example, by making a compound capable of reacting with a hydroxyl group or amino group contained in the polysaccharide, which includes the functional group or becomes the functional group by a reaction with the hydroxyl or amino group, to react with the polysaccharide by a dehydration reaction.
- the polysaccharide derivative is a carbamate derivative of polysaccharide or an ester derivative of polysaccharide as described in, for example, WO 95/23125 A1 and the like.
- the polysaccharide or the derivative thereof can be supported on the monolithic inorganic type carrier by distilling off a solvent from the monolithic inorganic type carrier filled with a solution of polysaccharide which contains the polysaccharide or the derivative thereof and the solvent, or replacing the solvent with another solvent, or performing both distilling off the solvent and replacing the solvent with the other solvent.
- supported includes a direct or indirect physical adsorption of the monolithic inorganic type carrier with the polysaccharide or the derivative thereof, and a direct or indirect chemical bond of the monolithic inorganic type carrier with the polysaccharide or the derivative thereof.
- the solvent may be distilled off to some extent and subsequently the remaining solvent may be replaced with the other solvent, or the solvent may be replaced with the other solvent and subsequently the remaining solvent may be distilled off.
- any organic solvents typically used may be used so long as they can dissolve the polysaccharide or the derivative thereof.
- the solvent examples include: as ketone based solvents, acetone, ethylmethylketone, and acetophenone; as ester based solvents, ethyl acetate, methyl acetate, propyl acetate, methyl propionate, methyl benzoate, and phenyl acetate; as ether based solvents, tetrahydrofuran, 1,4-dioxane, diethylether, and tert-butylmethylether; as amide based solvents, N,N-dimethylformamide and N,N-dimethylacetamide; as imide based solvents, N,N-dimethylimidazolidinone; as halogen based solvents, chloroform, methylene chloride, carbon tetrachloride, and 1,2-dichloroethane; as hydrocarbon based solvents, pentane, petroleum ether, hexane, heptane, octane
- the other solvent is not particularly limited so long as it is a solvent which replaces the solvent from the solution of polysaccharides, but is preferably a solvent which replaces in favor of the solvent from the solution of the polysaccharides.
- a solvent which is insoluble or poorly soluble for the polysaccharide or the derivative thereof is preferable, and can be appropriately selected from known solvents depending on conditions such as solubility for the polysaccharide or the derivative thereof and compatibility with the above solvent.
- Supercritical fluid can be used as a solvent which dissolves the polysaccharide and the derivative thereof.
- the supercritical fluid referred to herein is referred to fluid at a supercritical temperature and/or pressure at which gas and liquid can coexist or above.
- this supercritical fluid it is preferable to use carbon dioxide, nitrogen monoxide, ammonia, sulfur dioxide, hydrogen halide, hydrogen sulfide, methane, ethane, propane, ethylene, propylene, halogenated hydrocarbon, and the like, and carbon dioxide is more preferable.
- An organic solvent can be added to the supercritical fluid.
- this organic solvent it is preferable to use alcohols such as ethanol, methanol and 2-propanol; organic acids such as acetic acid and propionic acid; amines such as diethylamine; aldehydes such as acetaldehyde; and ethers such as tetrahydrofuran and ethyl ether.
- An addition amount of the organic solvent is preferably from 1 to 50%, more preferably from 1 to 35%, and still preferably from 1 to 20% based on the supercritical fluid.
- a concentration of the solvent is from 1 to 100 parts by mass, preferably from 1 to 50 parts by mass, and more preferably from 1 to 20 parts by mass based on 1 part by mass of the polysaccharide or the derivative thereof.
- the monolithic inorganic type carrier having a meso pore of the above-mentioned pore size can support a larger amount of the polysaccharides in the meso pore compared with that of the conventional monolithic inorganic type carrier.
- the monolithic inorganic type carrier having a meso pore of the above-mentioned pore size can facilitate transfer of a substance into and out of the meso pore compared with that of the conventional monolithic inorganic type carrier.
- the monolithic inorganic type carrier can support a sufficient amount of the polysaccharides on a wall surface of the meso pore even when a solution of the polysaccharides having a relatively high viscosity is used.
- the separating agent for optical isomers of the invention can be manufactured by a method including the steps of filling the solution of polysaccharides into the monolithic inorganic type carrier, and at least one of distilling off the solvent from the monolithic inorganic type carrier in which the solution is filled and replacing the solvent with the other solvent in the monolithic inorganic type carrier in which the solution is filled.
- the step of filling the solution of polysaccharides into the monolithic inorganic type carrier includes a method of directly immersing the monolithic inorganic type carrier in the solution of polysaccharides and a method of passing the solution of polysaccharides through the monolithic inorganic type carrier with pressure. It is preferred that the step of filling the solution of polysaccharides into the monolithic inorganic type carrier is performed under pressure.
- the pressure at that time is preferably from 50 to 400 bar, more preferably from 50 to 200 bar.
- a method of applying pressure to the solution toward the monolithic inorganic type carrier is not particularly limited, and includes the application of pressure by high pressure gas from a bomb or a compressor, and the application of pressure by a pump used in HPLC.
- an appropriate method is selected depending on the type of the solution.
- Such a method includes, for example, drying under normal pressure and drying under reduced pressure. In the invention, such methods may be used alone or in combination.
- the step of replacing the solvent with another solvent in the monolithic inorganic type carrier in which the solution is filled includes a method of directly immersing the monolithic inorganic type carrier in which the solution is filled in the other solvent and a method of passing the other solvent through the monolithic inorganic type carrier with pressure, similarly to the step of filling the solution of polysaccharides into the monolithic inorganic type carrier.
- the support of the polysaccharide or the derivative thereof on the monolithic inorganic type carrier may be performed at one step or may be repeatedly performed at multiple steps, but it is preferred that it is performed at preferably from 1 to 5 steps, more preferably from 1 to 3 steps, and still preferably 1 step.
- the separating agent for optical isomers of the invention may perform stronger fixation of the polysaccharide or the derivative thereof on the monolithic inorganic type carrier by forming further chemical bonds by chemical bonds between the monolithic inorganic type carrier and the polysaccharide or the derivative thereof, chemical bonds between the polysaccharides or the derivatives thereof on the monolithic inorganic type carrier, chemical bonds using a third component, reactions by photo irradiation, irradiation of radioactive rays such as ⁇ -rays, and irradiation of electromagnetic waves such as microwaves to the polysaccharide or the derivative thereof on the monolithic inorganic type carrier, radical reactions, and the like. According to such strong fixation, when used for the separation of the optical isomers, further improvement of availability in industries is anticipated in the separation, analysis and fractionation etc. of the optical isomers.
- Examples of a method of fixing the polysaccharide or the derivative thereof on the monolithic inorganic type carrier by the chemical bond include, a method including the steps of binding the monolithic inorganic type carrier to a binder which is fixed on the surface of this monolithic inorganic type carrier by the chemical bond, accreting the polysaccharide or the derivative thereof to the monolithic inorganic type carrier to which the binder is bound, and directly or indirectly binding the accreting polysaccharide or derivative thereof with the binder.
- This method may further include the step of introducing substituents into the polysaccharide or the derivative thereof which binds to the binder.
- substituents into the polysaccharide or the derivative thereof which binds to the binder.
- the binder is not particularly limited so long as it is a compound which is fixed to the surface of the monolithic inorganic type carrier by the chemical bond and can further chemically bind to the polysaccharide or the derivative thereof. Also, the binder and the polysaccharide or the derivative thereof may be directly bound chemically, or indirectly bound chemically via another compound such as a crosslinking agent.
- the binder is appropriately selected depending on a composition of the surface of the monolithic inorganic type carrier, and the preferable binders include, for example, organic silicon compounds such as silane coupling agents.
- the separation column for optical isomers of the invention has a column tube and the separating agent for optical isomers held in this column tube.
- the column tube typically used can be used depending on a use form of the column and a scale of the column.
- the separating agent for optical isomers is held in the column tube to become a channel for fluid within the column tube.
- a method of holding the separating agent for optical isomers in the column tube is not particularly limited so long as it is the method capable of sealing space between an inner wall face of the column tube and a surface opposite thereto of the separating agent for optical isomers.
- Known methods can be used in which the monolithic inorganic type carrier is held in the column tube. As such a method, for example, as disclosed in JP 2002-505005 A, it is possible to use a method of sealing the space between the inner wall face of the column tube and the surface opposite thereto of the monolithic inorganic type carrier by plastic, and the like.
- the separation column for optical isomers of the invention may be manufactured by holding the separating agent for optical isomers in the column tube, or may be manufactured by supporting the polysaccharide or the derivative thereof by the aforementioned steps on the monolithic inorganic type carrier of the column having the monolithic inorganic type carrier held in the column tube to become a channel of fluid within the column tube.
- the method of supporting the polysaccharide or the derivative thereof in the column having the monolithic inorganic type carrier is preferable from the viewpoint of prevention of decomposition of the supported polysaccharide or derivative thereof, ease of the manufacture, and the like.
- the separation column for optical isomers of the invention is generally used for chromatography methods such as gas chromatography, high-performance liquid chromatography, supercritical chromatography, thin layer chromatography, and capillary electrophoresis.
- chromatography methods such as gas chromatography, high-performance liquid chromatography, supercritical chromatography, thin layer chromatography, and capillary electrophoresis.
- Amylose tris(3,5-dimethylphenylcarbamate) synthesized in (1) was dissolved in ethyl acetate. A concentration of the solution was 75 mg/mL.
- a monolithic inorganic porous body which has a macropore having a pore size of 1.9 ⁇ m and a meso pore having a pore size of 25 nm formed on an inner wall surface of the macropore, was used as a monolithic inorganic type porous body.
- the solution was injected into a monolithic inorganic type porous body column from an end part using a pump for HPLC at a pressure within a maximum pressure of 200 bar.
- the monolithic inorganic type porous body column has the monolithic inorganic porous body held in a column tube having a length of 50 mm and an inner diameter of 4.6 mm.
- the injection of the solution was stopped after the solution containing the polysaccharide derivative was observed from a tip part of the inorganic type porous body column (end part of the inorganic type porous body column opposite to the end part connecting with the pump) . Both ends of the inorganic type porous body column were opened, and the inorganic type porous body column was dried under normal temperature and normal pressure for about 1 week and then dried under reduced pressure for 4 hours. A weight of the inorganic type porous body column was measured before and after drying to determine an end point of a drying step. As described above, an inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced.
- An inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced in the same manner as that in Example 1 except that a monolithic inorganic type porous body column holding a monolithic porous body, which has a macropore having a pore size of 4.5 ⁇ m and a meso pore having a pore size of 23 nm, in the column tube, was used in place of the monolithic inorganic type porous body column used in Example 1.
- An inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced in the same manner as that in Example 1 except that a monolithic inorganic type porous body column holding a monolithic porous body, which has a macropore having a pore size of 6.0 ⁇ m and a meso pore having a pore size of 24.4 nm, in the column tube, was used in place of the monolithic inorganic type porous body column used in Example 1.
- An inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced in the same manner as that in Example 1 except that a monolithic inorganic type porous body column holding a monolithic porous body, which has a macropore having a pore size of 1.8 ⁇ m and a meso pore having a pore size of 10.9 nm, in the column tube, was used in place of the monolithic inorganic type porous body column used in Example 1.
- An inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced in the same manner as that in Example 1 except that a monolithic inorganic type porous body column holding a monolithic porous body, which has a macropore having a pore size of 4.5 ⁇ m and a meso pore having a pore size of 10.2 nm, in the column tube, was used in place of the monolithic inorganic type porous body column used in Example 1.
- An inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced in the same manner as that in Example 1 except that a monolithic inorganic type porous body column holding a monolithic porous body, which has a macropore having a pore size of 5.74 ⁇ m and a meso pore having a pore size of 10.0 nm, in the column tube, was used in place of the monolithic inorganic type porous body column used in Example 1.
- the inorganic type porous body columns produced in Examples 1 to 3 and the inorganic type porous body columns produced in Comparative Examples 1 to 3 were each used for separation of optical isomers shown in Table 1 by liquid chromatography. A retention time of each of the optical isomers in each of the columns was measured, to thereby determine a separation factor a and the number of theoretical plates for each of the columns. Table 1 shows the separation factor ⁇ , and Table 2 shows the number of theoretical plates.
- the separation factor ⁇ in Table 1 is determined by the following equation (1).
- k 1 ′ represents a capacity ratio of an optical isomer eluted faster among the separated optical isomers
- k 2 ′ represents a capacity ratio of an optical isomer eluted slower among the separated optical isomers.
- the capacity ratio k r ′ is determined by the following equation (2).
- t r represents a retention time of an optical isomer
- t 0 represents an elution time of tri-tert-butylbenzene.
- the number of theoretical plates N in Table 2 is determined by the following equation (3).
- W 0.5 represents a peak width at half height.
- the peak width W refers to a distance (time) between cross points of tangent lines drawn at inflection points of the peak on both sides of the peak, and a base line.
- An amount of the polymer supported in Table 2 refers to a difference (mg) between a mass of the inorganic type porous body column having a polymer supported thereon and a mass of the inorganic type porous body column not having the polymer supported thereon.
- Tables 1 and 2 clearly show that the inorganic type porous body column produced in each of Examples exhibits better performance as a separation column for optical isomers compared with the inorganic type porous body column produced in each of Comparative Examples.
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
This invention provides a separating agent for optical isomers, which has high asymmetry recognition ability and can be used particularly at a high flow rate when used for the separation of the optical isomers, and a separation column for optical isomers having the same. This invention provides: a separating agent for optical isomers which is used for separation of optical isomers in a sample comprising the optical isomers, which is comprising a monolithic inorganic type carrier having a meso pore formed on an inner wall surface of a specific macropore, and a polysaccharide or a polysaccharide derivative supported on the monolithic inorganic type carrier, wherein the meso pore has a pore size of 6 to 100 nm; and a separation column for optical isomers in which the separating agent for optical isomers is held in a column tube.
Description
- The present application is a divisional application based upon application Ser. No. 11/806,033, filed on May 29, 2007, to which priority is claimed under 35 U.S.C. §120. Application Ser. No. 11/806,033 is a continuation of international application PCT/JP2005/021913, filed on Nov. 29, 2005, which designated the United States, to which priority is also claimed under 35 U.S. §120. This application claims priority under 35 U.S.C. §119(a) to patent application no. 2004-343683 filed in Japan on Nov. 29, 2004. The contents of each of the foregoing applications is hereby incorporated by reference.
- 1. Field of the Invention
- The present invention relates to a separation column for optical isomers, and more particularly to a separation column for optical isomers used for separation of the optical isomers by chromatography. In particular, the invention relates to a separation column for optical isomers which efficiently separates a broad range of compounds in the separation of pharmaceuticals, foods, agricultural chemicals and perfumes.
- 2. Description of Related Art
- Optical isomers having a relationship of a real image and a mirror image have the same physical and chemical properties such as a boiling point, a melting point, and solubility, but often show differences in interactions for a living matter such as a bioactive including taste and odor. In particular, in the field of pharmaceutical preparations, there are significant differences in an effect of a medicine and toxicity between the two optical isomers. Therefore, in the Guideline for the Production of Pharmaceuticals, the Ministry of Health, Labor and Welfare describes that “when a drug is a racemic modification, it is desirable to preliminarily study absorption, distribution, metabolism and movement of excretion for each isomer”.
- As stated above, optical isomers have completely the same physical and chemical properties such as a boiling point, a melting point, and solubility, therefore, each optical isomer could not be separated by classical, ordinary separation means and it was not possible to study on interaction of an individual optical isomer with the living matter. Thus, energetic studies have been made on techniques for separating optical isomers in order to analyze a wide variety of optical isomers conveniently with high precision.
- And as a separation technique that meets these requirements, an optical resolution method by high performance liquid chromatography (HPLC), in particular an optical resolution method by separation columns for optical isomers for HPLC has progressed. As the separation columns for optical isomers referred to herein, a chiral stationary phase composed of an asymmetry recognition agent itself or a chiral stationary phase composed of an asymmetry recognition agent supported on a suitable carrier is used.
- Known examples of the asymmetry recognition agent include optical active triphenylmethyl polymethacrylate (see e.g., JP 57-150432 A), cellulose, amylose derivatives (see, e.g. , Okamoto Y., Kawashima M., and Hatada K., J. Am. Chem. Soc., 106:5357, 1984), and ovomucoid which is protein (see e.g., JP 63-307829 A).
- Meanwhile, in a column configured by filling a particulate inorganic type filler such as silica gel into a tube, resistance to flow of fluid is first increased and thus pressure drop is increased. Consequently, a flow per unit time period is reduced, and a long time is required for the separation when used as chromatography. Additionally, since the flow per unit time period is small, productivity per unit time period is small, and generally it has not been adequate to mass production of separation subjects.
- As a column to dissolve this drawback, a column made up of a monolithic inorganic type porous body (see e.g., JP 6-265534 A) has been known. As a method of producing such a column made up of an monolithic inorganic type porous body, the method of sealing a space between the inorganic type porous body and a column tube by softening plastic or glass with heat has been known (see e.g., JP 2002-505005 A). Moreover, a separation column for optical isomers where cyclodextrin as an asymmetry recognition agent is chemically bound to a monolithic inorganic type porous body has been known (see e.g., JP 2000-515627 A).
- However, in the manufacture of currently known separation columns for optical isomers using the monolithic inorganic type porous body, there are some cases where reactivity of the monolithic inorganic type porous body with the asymmetry recognition agent is low. Besides, there are some cases where the asymmetry recognition agent chemically bound to the monolithic inorganic type porous body is decomposed at the manufacture of columns. Depending on conditions of the column manufacture, the asymmetry recognition agent used is sometimes limited and there are some cases where the column cannot be applied to a broad range of optical isomers. There have been problems described above in the manufacture of the separation columns for optical isomers, and tasks still remain for practical application thereof.
- It is an object of the invention to provide a separating agent for optical isomers which has high asymmetry recognition ability and can be used particularly at a high flow rate when used for the separation of the optical isomers, and a separation column for optical isomers having the same.
- As a result of an intensive study on a separating agent for optical isomers having characteristic asymmetry recognition ability, the inventors of the present invention have accomplished the present invention.
- That is, the present invention is a separating agent for optical isomers which is used for separation of optical isomers in a sample comprising the optical isomers, which is comprising a monolithic inorganic type carrier, and at least one of a polysaccharide and a polysaccharide derivative supported on the monolithic inorganic type carrier, wherein: the monolithic inorganic type carrier comprises a porous body in which channels are formed through connection of cavities from one end to the other end of the monolithic inorganic type carrier; the cavities each comprise a macropore and a meso pore formed on an inner wall surface of the macropore; and the meso pore has a pore size of 6 to 100 nm.
- Further, the present invention provides a separation column for optical isomers, comprising: a column tube; and the above-mentioned separating agent for optical isomers which is held in the column tube.
- According to the present invention, a monolithic inorganic type carrier having a specific meso pore formed on the inner wall surface of the macropore is used, and at least one of a polysaccharide and a polysaccharide derivative capable of separating optical isomers is supported on the monolithic inorganic type carrier. Thus, the present invention provides a separating agent for optical isomers having high asymmetry identifying ability and a separation column for optical isomers which can be used in separation, analysis, and fractionation of a wide variety of optical isomers at a high flow rate.
- Hereinafter, an embodiment of the invention is illustrated in detail.
- The separating agent for optical isomers of the invention has a porous monolithic inorganic type carrier and polysaccharide or a derivative thereof supported on this monolithic inorganic type carrier. In the invention, the polysaccharide or the derivative thereof may be directly supported on the monolithic inorganic type carrier, or may be supported through another compound which is appropriate.
- The monolithic inorganic type carrier is generally a cylindrical inorganic type porous body which may be held in a column tube and has a flow path formed through connection of cavities from one end to the other end of the monolithic inorganic type carrier. That is, the monolithic inorganic type carrier is different from a particulate carrier filled in the column tube.
- The monolithic inorganic type carrier preferably contains silica as a major ingredient, but may be comprised of another inorganic material and may contain a small amount of an organic material. When silica is the major ingredient, it is desirable that surface treatment is given to the monolithic inorganic type carrier in order to exclude an effect of a residual silanol group, but there is no problem even if the surface treatment is not given.
- The monolithic inorganic type carrier may employ a known inorganic type carrier or an improved article thereof.
- Examples thereof include: a porous shaped body described in JP 2000-515627 A; a monolithic adsorbent described in JP 2002-505005 A; and an inorganic porous column described in JP H06-265534 A.
- The monolithic inorganic type carrier can be made by known methods and methods according thereto. The monolithic inorganic type carrier can be manufactured by, for example, a sol-gel method where a structure with a solvent rich phase which becomes a huge void is caused by using metal alkoxide as a starting material and adding an appropriate coexisting substance such as a polymer such as polyoxyethylene which dissolves in a solvent to the material as described in JP 7-41374 A.
- The cavities forming the channels each have a macropore and a meso pore formed on an inner surface wall of the macropore. A pore size of the macropore may be controlled in accordance with a particle size of the coexisting substance, for example. A pore size of the meso pore may be controlled by solidifying a product of the sol-gel method and then immersing the product in an acidic aqueous solution or a basic aqueous solution, for example.
- The macropore is not particularly limited so long as the pore forms channels passing through the monolithic inorganic type carrier along a direction of a flow of a mobile phase when the monolithic inorganic type carrier is provided in a flow path of the mobile phase. The channels formed through connecting of the macropores may consist of pores in a straight line or pores continuing in a three dimensional network. The channels preferably consists of the pores continuing in a three dimensional network from the viewpoint of improving separation performance.
- Too small a pore size of the macropore may cause difficulties in sufficiently supporting on a monolithic inorganic type carrier a polysaccharide or a polysaccharide derivative for separating optical isomers. Too large a pore size of the macropore may result in insufficient performance of separating optical isomers. From such viewpoints, a pore size of the macropore is preferably 0.5 to 30 μm, more preferably 0.5 to 10 μm, futhermore preferably 1.0 to 6.0 μm, still more preferably 1.0 to 4.5 μm.
- Too small a pore size of the meso pore may result in:
- difficulties in sufficiently supporting on the monolithic inorganic type carrier a polysaccharide or a polysaccharide derivative for separating optical isomers; prevention of optical isomers in a sample from sufficiently approaching a polysaccharide or a polysaccharide derivative; and insufficient separation of optical isomers by a polysaccharide or a polysaccharide derivative. A pore size of the meso pore can be increased to a level (several hundred nm) distinguished from that of the macropore. However, too large a pore size of the meso pore may result in: a reduced effect of surface area expansion by providing the meso pore; a reduced amount of a polysaccharide or a polysaccharide derivative supported on a monolithic inorganic type carrier; and insufficient separation of optical isomers by a polysaccharide or a polysaccharide derivative. From the above viewpoints, a pore size of the meso pore is preferably 6 to 100 nm, more preferably 15 to 80 nm, furthermore preferably 20 to 60 nm, and still more preferably 20 to 50 nm.
- The pore size of the macropore can be represented by a value which can represent a substantial pore size of the macropore in the monolithic inorganic type carrier. For example, the pore size of the macropore can be represented by the median of the pore size distribution of the macropore in the monolithic inorganic type carrier. The pore size distribution of the macropore can be measured by using mercury porosimetry or raster electron microscope.
- The pore size of the meso pore can be represented by a value which can represent a substantial pore size of the meso pore in the monolithic inorganic type carrier. For example, the pore size of the meso pore can be represented by the median of the pore size distribution of the meso pore in the monolithic inorganic type carrier. The pore size distribution of the meso pore can be measured by using mercury porosimetry, BET method with nitrogen adsorption, or inverse exclusion chromatography (ISEC).
- In particular, the monolithic inorganic type carrier has a macropore having a pore size of 0.5 to 10 μm and a meso pore having a pore size of 15 to 80 nm, preferably a macropore having a pore size of 1.0 to 6.0 μm and a meso pore having a pore size of 20 to 60 nm, more preferably a macropore having a pore size of 1.0 to 4.5 μm and a meso pore having a pore size of 20 to 50 nm.
- The polysaccharide may be any of synthetic polysaccharide, naturally occurring polysaccharide and naturally occurring modified polysaccharide, and may be any polysaccharide so long as it is optically active, but those with high regularity of binding manner are preferable, and chain-shaped ones are also preferable.
- Examples of the polysaccharide include: β-1,4-glucan (cellulose), α-1,4-glucan (amylose or amylopectin), α-1,6-glucan (dextran), β-1,6-glucan (pustulan), β-1,3-glucan (such as curdlan and schizophyllan), α-1,3-glucan, β-1,2-glucan (Crown Gall polysaccharide), β-1,4-galactan, β-1,4-mannan, α-1,6-mannan, β-1,2-fructan (inulin), β-2,6-fructan (levan), β-1,4-xylan, β-1,3-xylan, β-1,4-chitosan, α-1,4-N-acetylchitosan (chitin), pullulan, agarose, and alginic acid. Also, starches containing amylose are included therein.
- Of those, it is preferable to use those which can be easily obtained as highly pure polysaccharides such as cellulose, amylose, β-1,4-xylan, β-1,4-chitosan, chitin, β-1,4-mannan, inulin, and curdlan, and more preferably cellulose and amylose.
- It is preferred that such a polysaccharide has a number-average degree of polymerization (i.e., the average number of pyranose or furanose rings per molecule) of 5 or more, and more preferably of 10 or more . From the viewpoint of easy handling, it is preferred that the number-average degree of polymerization is 1,000 or less, although the upper limit thereof is not particularly limited. Particularly, it is preferred that a number-average degree of polymerization of polysaccharide is from 50 to 400 in that the polysaccharide or the derivative thereof is supported on the inner wall face of the monolithic inorganic type carrier having meso pores and a sufficient separation effect of the optical isomers is obtained.
- The polysaccharide derivative is not particularly limited so long as it is the polysaccharide derivative which can be used for the separation of optical isomers. Such polysaccharide derivatives include, for example, polysaccharide derivatives which contain optical active polysaccharide as a skeleton and where at least a part of a hydroxyl group and an amino group which this polysaccharide has is substituted with a functional group which acts on an optical isomer in a sample.
- The functional group is a functional group which acts on the optical isomer in the sample containing the optical isomers which are subject to the separation. Actions of the functional group for the optical isomer cannot be collectively defined because a type of the functional group is different depending on a type of the optical isomers which are subject to the separation, but they are not particularly limited so long as they are the actions sufficient to perform optical resolution of the optical isomers by the polysaccharide derivatives.
- Such actions include affinitive interactions such as hydrogen bond, π-π interaction and dipole-dipole interaction of the optical isomer with the functional group, and non-affinitive interaction such as steric hindrance. By such interactions, it is believed that when a pair of the optical isomers gets close to the polysaccharide derivative, a direction of the optical isomer can be arranged without disturbing access of at least one or the optical isomers to the polysaccharide derivative or a higher structure of the polysaccharide derivative itself can be arranged in a shape favorable for asymmetry recognition.
- The functional group is selected depending on the type of the optical isomers which are subject to the separation. The functional groups include groups including aromatic groups which are bound to the polysaccharide, for example via ester bond, urethane bond and ether bond and which may have substituents. The aromatic groups include heterocyclic rings and condensed rings. Substituents which the aromatic group may have include, for example, alkyl groups with up to about 8 carbons, halogen, amino groups, and alkoxy groups.
- A degree of substitution of the functional group is not particularly limited. The functional group may be substituted with part or all of the hydroxyl groups and amino groups of the polysaccharide, for example. The degree of substitution of the functional group is arbitrarily selected depending on various conditions such as a type of the functional group and a type of the polysaccharide. To be specific, a degree of substitution of the functional group is preferably 50 to 100%, more preferably 80 to 100%. The degree of substitution of the functional group can be measured through elemental analysis, for example.
- The polysaccharide derivative can be made by known methods. The polysaccharide derivative can be made, for example, by making a compound capable of reacting with a hydroxyl group or amino group contained in the polysaccharide, which includes the functional group or becomes the functional group by a reaction with the hydroxyl or amino group, to react with the polysaccharide by a dehydration reaction. From the viewpoint of realizing the separation of a broad range of optical isomers, it is particularly preferred that the polysaccharide derivative is a carbamate derivative of polysaccharide or an ester derivative of polysaccharide as described in, for example, WO 95/23125 A1 and the like.
- The polysaccharide or the derivative thereof can be supported on the monolithic inorganic type carrier by distilling off a solvent from the monolithic inorganic type carrier filled with a solution of polysaccharide which contains the polysaccharide or the derivative thereof and the solvent, or replacing the solvent with another solvent, or performing both distilling off the solvent and replacing the solvent with the other solvent.
- The term “supported” referred to herein includes a direct or indirect physical adsorption of the monolithic inorganic type carrier with the polysaccharide or the derivative thereof, and a direct or indirect chemical bond of the monolithic inorganic type carrier with the polysaccharide or the derivative thereof.
- When both distilling off the solvent and replacing the solvent with the other solvent are performed, the solvent may be distilled off to some extent and subsequently the remaining solvent may be replaced with the other solvent, or the solvent may be replaced with the other solvent and subsequently the remaining solvent may be distilled off.
- As the solvent (good solvent) used for dissolution of the polysaccharide or the derivative thereof, any organic solvents typically used may be used so long as they can dissolve the polysaccharide or the derivative thereof.
- Examples of the solvent include: as ketone based solvents, acetone, ethylmethylketone, and acetophenone; as ester based solvents, ethyl acetate, methyl acetate, propyl acetate, methyl propionate, methyl benzoate, and phenyl acetate; as ether based solvents, tetrahydrofuran, 1,4-dioxane, diethylether, and tert-butylmethylether; as amide based solvents, N,N-dimethylformamide and N,N-dimethylacetamide; as imide based solvents, N,N-dimethylimidazolidinone; as halogen based solvents, chloroform, methylene chloride, carbon tetrachloride, and 1,2-dichloroethane; as hydrocarbon based solvents, pentane, petroleum ether, hexane, heptane, octane, benzene, toluene, xylene, and mesitylene; as urea based solvents, tetramethyl urea; as alcohol based solvents, methanol, ethanol, propanol, and butanol; as acid based solvents, acetic acid, trifluoroacetic acid, formic acid, phenol, and catechol; and as amine based solvents, diethylamine, triethylamine, and pyridine. These solvents may be used alone or in mixture with multiple types.
- The other solvent (poor solvent) is not particularly limited so long as it is a solvent which replaces the solvent from the solution of polysaccharides, but is preferably a solvent which replaces in favor of the solvent from the solution of the polysaccharides. As such another solvent, a solvent which is insoluble or poorly soluble for the polysaccharide or the derivative thereof is preferable, and can be appropriately selected from known solvents depending on conditions such as solubility for the polysaccharide or the derivative thereof and compatibility with the above solvent.
- Supercritical fluid can be used as a solvent which dissolves the polysaccharide and the derivative thereof. The supercritical fluid referred to herein is referred to fluid at a supercritical temperature and/or pressure at which gas and liquid can coexist or above. As this supercritical fluid, it is preferable to use carbon dioxide, nitrogen monoxide, ammonia, sulfur dioxide, hydrogen halide, hydrogen sulfide, methane, ethane, propane, ethylene, propylene, halogenated hydrocarbon, and the like, and carbon dioxide is more preferable.
- An organic solvent can be added to the supercritical fluid. As this organic solvent, it is preferable to use alcohols such as ethanol, methanol and 2-propanol; organic acids such as acetic acid and propionic acid; amines such as diethylamine; aldehydes such as acetaldehyde; and ethers such as tetrahydrofuran and ethyl ether. An addition amount of the organic solvent is preferably from 1 to 50%, more preferably from 1 to 35%, and still preferably from 1 to 20% based on the supercritical fluid.
- When filling the solution of polysaccharides into the monolithic inorganic type carrier, a concentration of the solvent is from 1 to 100 parts by mass, preferably from 1 to 50 parts by mass, and more preferably from 1 to 20 parts by mass based on 1 part by mass of the polysaccharide or the derivative thereof.
- The monolithic inorganic type carrier having a meso pore of the above-mentioned pore size can support a larger amount of the polysaccharides in the meso pore compared with that of the conventional monolithic inorganic type carrier.
- Further, the monolithic inorganic type carrier having a meso pore of the above-mentioned pore size can facilitate transfer of a substance into and out of the meso pore compared with that of the conventional monolithic inorganic type carrier. Thus, the monolithic inorganic type carrier can support a sufficient amount of the polysaccharides on a wall surface of the meso pore even when a solution of the polysaccharides having a relatively high viscosity is used.
- The separating agent for optical isomers of the invention can be manufactured by a method including the steps of filling the solution of polysaccharides into the monolithic inorganic type carrier, and at least one of distilling off the solvent from the monolithic inorganic type carrier in which the solution is filled and replacing the solvent with the other solvent in the monolithic inorganic type carrier in which the solution is filled.
- The step of filling the solution of polysaccharides into the monolithic inorganic type carrier includes a method of directly immersing the monolithic inorganic type carrier in the solution of polysaccharides and a method of passing the solution of polysaccharides through the monolithic inorganic type carrier with pressure. It is preferred that the step of filling the solution of polysaccharides into the monolithic inorganic type carrier is performed under pressure. The pressure at that time is preferably from 50 to 400 bar, more preferably from 50 to 200 bar. A method of applying pressure to the solution toward the monolithic inorganic type carrier is not particularly limited, and includes the application of pressure by high pressure gas from a bomb or a compressor, and the application of pressure by a pump used in HPLC.
- As the step of distilling off the solvent from the monolithic inorganic type carrier in which the solution is filled, an appropriate method is selected depending on the type of the solution. Such a method includes, for example, drying under normal pressure and drying under reduced pressure. In the invention, such methods may be used alone or in combination.
- The step of replacing the solvent with another solvent in the monolithic inorganic type carrier in which the solution is filled includes a method of directly immersing the monolithic inorganic type carrier in which the solution is filled in the other solvent and a method of passing the other solvent through the monolithic inorganic type carrier with pressure, similarly to the step of filling the solution of polysaccharides into the monolithic inorganic type carrier.
- When the step of filling the solution of polysaccharides into the monolithic inorganic type carrier, and the step of at least one of distilling off the solvent from the monolithic inorganic type carrier in which the solution is filled and replacing the solvent with the other solvent therein are made into one step of supporting the polysaccharide or the derivative thereof on the monolithic inorganic type carrier, the support of the polysaccharide or the derivative thereof on the monolithic inorganic type carrier may be performed at one step or may be repeatedly performed at multiple steps, but it is preferred that it is performed at preferably from 1 to 5 steps, more preferably from 1 to 3 steps, and still preferably 1 step.
- The separating agent for optical isomers of the invention may perform stronger fixation of the polysaccharide or the derivative thereof on the monolithic inorganic type carrier by forming further chemical bonds by chemical bonds between the monolithic inorganic type carrier and the polysaccharide or the derivative thereof, chemical bonds between the polysaccharides or the derivatives thereof on the monolithic inorganic type carrier, chemical bonds using a third component, reactions by photo irradiation, irradiation of radioactive rays such as γ-rays, and irradiation of electromagnetic waves such as microwaves to the polysaccharide or the derivative thereof on the monolithic inorganic type carrier, radical reactions, and the like. According to such strong fixation, when used for the separation of the optical isomers, further improvement of availability in industries is anticipated in the separation, analysis and fractionation etc. of the optical isomers.
- Examples of a method of fixing the polysaccharide or the derivative thereof on the monolithic inorganic type carrier by the chemical bond include, a method including the steps of binding the monolithic inorganic type carrier to a binder which is fixed on the surface of this monolithic inorganic type carrier by the chemical bond, accreting the polysaccharide or the derivative thereof to the monolithic inorganic type carrier to which the binder is bound, and directly or indirectly binding the accreting polysaccharide or derivative thereof with the binder.
- This method may further include the step of introducing substituents into the polysaccharide or the derivative thereof which binds to the binder. In the case of including such a step, it is possible to regulate a substitution ratio of the substituent in the polysaccharide derivative. In the case of including the step, it is also become possible to bind the polysaccharide to the binder and introduce the substituent including the functional group into the polysaccharide which binds to the binder.
- The binder is not particularly limited so long as it is a compound which is fixed to the surface of the monolithic inorganic type carrier by the chemical bond and can further chemically bind to the polysaccharide or the derivative thereof. Also, the binder and the polysaccharide or the derivative thereof may be directly bound chemically, or indirectly bound chemically via another compound such as a crosslinking agent. The binder is appropriately selected depending on a composition of the surface of the monolithic inorganic type carrier, and the preferable binders include, for example, organic silicon compounds such as silane coupling agents.
- The separation column for optical isomers of the invention has a column tube and the separating agent for optical isomers held in this column tube.
- As the column tube, the column tube typically used can be used depending on a use form of the column and a scale of the column.
- The separating agent for optical isomers is held in the column tube to become a channel for fluid within the column tube. A method of holding the separating agent for optical isomers in the column tube is not particularly limited so long as it is the method capable of sealing space between an inner wall face of the column tube and a surface opposite thereto of the separating agent for optical isomers. Known methods can be used in which the monolithic inorganic type carrier is held in the column tube. As such a method, for example, as disclosed in JP 2002-505005 A, it is possible to use a method of sealing the space between the inner wall face of the column tube and the surface opposite thereto of the monolithic inorganic type carrier by plastic, and the like.
- The separation column for optical isomers of the invention may be manufactured by holding the separating agent for optical isomers in the column tube, or may be manufactured by supporting the polysaccharide or the derivative thereof by the aforementioned steps on the monolithic inorganic type carrier of the column having the monolithic inorganic type carrier held in the column tube to become a channel of fluid within the column tube. The method of supporting the polysaccharide or the derivative thereof in the column having the monolithic inorganic type carrier is preferable from the viewpoint of prevention of decomposition of the supported polysaccharide or derivative thereof, ease of the manufacture, and the like.
- The separation column for optical isomers of the invention is generally used for chromatography methods such as gas chromatography, high-performance liquid chromatography, supercritical chromatography, thin layer chromatography, and capillary electrophoresis. In particular, it is preferable to apply the separation column to the high-performance liquid chromatography method.
- Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The preferred specific embodiments and examples are, therefore, to be construed as merely illustrative, and not limitative of the disclosure in any way whatsoever.
- The entire disclosures of all applications, patents, and publications cited above and below, and of corresponding application Japanese JP2004-343683, filed Nov. 29, 2004, are hereby incorporated by reference.
- The present invention is described below in more detail based on examples, but the invention is not limited to the following examples.
- Production of a monolithic inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate)
- (1) Synthesis of amylose tris(3,5-dimethylphenylcarbamate)
- In a nitrogen atmosphere, 10 g of amylose and 68.1 g (2.5 equivalents with respect to all of hydroxyl groups of amylose) of 3,5-dimethylphenyl isocyanate in 300 mL of dry pyridine were stirred under heating at 100° C. for 48 hours, and the whole was poured in to 3 L of methanol. A separated solid was filtered and collected on a glass filter, washed with methanol several times, and dried in a vacuum. As a result, 34 g of a yellowish white solid was obtained.
- (2) Supporting of amylose tris(3,5-dimethylphenylcarbamate) on a monolithic inorganic type porous body
- Amylose tris(3,5-dimethylphenylcarbamate) synthesized in (1) was dissolved in ethyl acetate. A concentration of the solution was 75 mg/mL.
- A monolithic inorganic porous body, which has a macropore having a pore size of 1.9 μm and a meso pore having a pore size of 25 nm formed on an inner wall surface of the macropore, was used as a monolithic inorganic type porous body. The solution was injected into a monolithic inorganic type porous body column from an end part using a pump for HPLC at a pressure within a maximum pressure of 200 bar. The monolithic inorganic type porous body column has the monolithic inorganic porous body held in a column tube having a length of 50 mm and an inner diameter of 4.6 mm. The injection of the solution was stopped after the solution containing the polysaccharide derivative was observed from a tip part of the inorganic type porous body column (end part of the inorganic type porous body column opposite to the end part connecting with the pump) . Both ends of the inorganic type porous body column were opened, and the inorganic type porous body column was dried under normal temperature and normal pressure for about 1 week and then dried under reduced pressure for 4 hours. A weight of the inorganic type porous body column was measured before and after drying to determine an end point of a drying step. As described above, an inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced.
- An inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced in the same manner as that in Example 1 except that a monolithic inorganic type porous body column holding a monolithic porous body, which has a macropore having a pore size of 4.5 μm and a meso pore having a pore size of 23 nm, in the column tube, was used in place of the monolithic inorganic type porous body column used in Example 1.
- An inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced in the same manner as that in Example 1 except that a monolithic inorganic type porous body column holding a monolithic porous body, which has a macropore having a pore size of 6.0 μm and a meso pore having a pore size of 24.4 nm, in the column tube, was used in place of the monolithic inorganic type porous body column used in Example 1.
- An inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced in the same manner as that in Example 1 except that a monolithic inorganic type porous body column holding a monolithic porous body, which has a macropore having a pore size of 1.8 μm and a meso pore having a pore size of 10.9 nm, in the column tube, was used in place of the monolithic inorganic type porous body column used in Example 1.
- An inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced in the same manner as that in Example 1 except that a monolithic inorganic type porous body column holding a monolithic porous body, which has a macropore having a pore size of 4.5 μm and a meso pore having a pore size of 10.2 nm, in the column tube, was used in place of the monolithic inorganic type porous body column used in Example 1.
- An inorganic type porous body column supporting amylose tris (3,5-dimethylphenylcarbamate) was produced in the same manner as that in Example 1 except that a monolithic inorganic type porous body column holding a monolithic porous body, which has a macropore having a pore size of 5.74 μm and a meso pore having a pore size of 10.0 nm, in the column tube, was used in place of the monolithic inorganic type porous body column used in Example 1.
- The inorganic type porous body columns produced in Examples 1 to 3 and the inorganic type porous body columns produced in Comparative Examples 1 to 3 were each used for separation of optical isomers shown in Table 1 by liquid chromatography. A retention time of each of the optical isomers in each of the columns was measured, to thereby determine a separation factor a and the number of theoretical plates for each of the columns. Table 1 shows the separation factor α, and Table 2 shows the number of theoretical plates.
-
TABLE 1 Separation factor α (−) Racemic Comparative Comparative Comparative modification Structural formula Example 1 Example 2 Example 3 example 1 example 2 example 3 t-SO 3.27 3.40 3.28 3.00 2.95 2.80 Bz 1.32 1.29 1.30 1.24 1.21 1.17 TR-base 1.29 1.28 1.28 1.14 1.12 1.00 TFAE 1.28 1.21 1.21 1.11 1.00 1.00 TrOH 2.28 2.25 2.28 2.28 2.19 2.22 Biph 2.29 2.33 2.30 2.24 2.26 2.23 -
TABLE 2 Amount of supported Pore size of Pore size of Number of theoretical plates N (—) polymer macropore meso pore t-SO Biph TrOH (mg) (μm) (nm) N1 N2 N1 N2 N1 N2 Example 1 110.3 1.9 25 2491 1738 1234 1077 1255 1137 Example 2 105.2 4.5 23 1616 1119 565 439 414 357 Example 3 104.8 6.0 24.4 1020 476 285 186 189 145 Comparative 116.7 1.8 10.9 2063 1471 1051 763 885 752 example 1 Comparative 107.4 4.5 10.2 1178 688 414 301 263 233 example 2 Comparative 100.1 5.74 10.0 654 287 170 111 109 77 example 3 - The separation factor α in Table 1 is determined by the following equation (1). In the equation (1), k1′ represents a capacity ratio of an optical isomer eluted faster among the separated optical isomers, and k2′ represents a capacity ratio of an optical isomer eluted slower among the separated optical isomers.
-
[Formula 1] -
separation factor (α)=k 2 ′/k 1′ (1) - The capacity ratio kr′ is determined by the following equation (2). In the equation (2), tr represents a retention time of an optical isomer, and t0 represents an elution time of tri-tert-butylbenzene.
-
[Formula 2] -
capacity ratio (k r′)=(t r −t 0)/t 0 (2) - The number of theoretical plates N in Table 2 is determined by the following equation (3). In the equation (3), W0.5 represents a peak width at half height. The peak width W refers to a distance (time) between cross points of tangent lines drawn at inflection points of the peak on both sides of the peak, and a base line.
-
[Formula 3] -
number of theoretical plates (N)=5.5×(t r /W 0.5)2 (3) - An amount of the polymer supported in Table 2 refers to a difference (mg) between a mass of the inorganic type porous body column having a polymer supported thereon and a mass of the inorganic type porous body column not having the polymer supported thereon.
- Tables 1 and 2 clearly show that the inorganic type porous body column produced in each of Examples exhibits better performance as a separation column for optical isomers compared with the inorganic type porous body column produced in each of Comparative Examples.
Claims (6)
1. A separating agent for optical isomers which is used for separation of optical isomers in a sample comprising the optical isomers, which separating agent comprises a monolithic inorganic type carrier, and at least one of a polysaccharide and a polysaccharide derivative supported on the monolithic inorganic type carrier, wherein:
the monolithic inorganic type carrier comprises a porous body in which channels are formed through connection of cavities from one end to the other end of the monolithic inorganic type carrier;
the cavities each comprise a macropore and a meso pore formed on an inner wall surface of the macropore;
the macropore has a pore size of 0.5 to 30 μm;
the meso pore has a pore size of 20 to 50 nm; and
the polysaccharide is cellulose.
2. The separating agent for optical isomers according to claim 1 , wherein the macropore has a pore size of 0.5 to 10 μm.
3. The separating agent for optical isomers according to claim 2 , wherein the macropore has a pore size of 1.0 to 6.0 μm.
4. The separating agent for optical isomers according to claim 1 , wherein the monolithic inorganic type carrier is mainly composed of silica.
5. The separating agent for optical isomers according to claim 1 , wherein the polysaccharide derivative is one of an ester derivative of cellulose and a carbamate derivative of cellulose.
6. A separation column for optical isomers comprising a column tube and the separating agent for optical isomers according to claim 1 or 2 which is held in the column tube.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/979,006 US20110089095A1 (en) | 2004-11-29 | 2010-12-27 | Separating agent for optical isomers and separation column for optical isomers |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004-343683 | 2004-11-29 | ||
| JP2004343683A JP2006150214A (en) | 2004-11-29 | 2004-11-29 | Separation agent for optical isomers and separation column for optical isomers |
| PCT/JP2005/021913 WO2006057412A1 (en) | 2004-11-29 | 2005-11-29 | Separating agent for optical isomer and separation column for optical isomers |
| US11/806,033 US8883001B2 (en) | 2004-11-29 | 2007-05-29 | Separating agent for optical isomers and separation column for optical isomers |
| US12/979,006 US20110089095A1 (en) | 2004-11-29 | 2010-12-27 | Separating agent for optical isomers and separation column for optical isomers |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/806,033 Division US8883001B2 (en) | 2004-11-29 | 2007-05-29 | Separating agent for optical isomers and separation column for optical isomers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20110089095A1 true US20110089095A1 (en) | 2011-04-21 |
Family
ID=36498146
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/806,033 Active 2031-06-17 US8883001B2 (en) | 2004-11-29 | 2007-05-29 | Separating agent for optical isomers and separation column for optical isomers |
| US12/979,031 Active 2028-08-14 US8883002B2 (en) | 2004-11-29 | 2010-12-27 | Separating agent for optical isomers and separation column for optical isomers |
| US12/979,006 Abandoned US20110089095A1 (en) | 2004-11-29 | 2010-12-27 | Separating agent for optical isomers and separation column for optical isomers |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/806,033 Active 2031-06-17 US8883001B2 (en) | 2004-11-29 | 2007-05-29 | Separating agent for optical isomers and separation column for optical isomers |
| US12/979,031 Active 2028-08-14 US8883002B2 (en) | 2004-11-29 | 2010-12-27 | Separating agent for optical isomers and separation column for optical isomers |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US8883001B2 (en) |
| EP (1) | EP1818675B1 (en) |
| JP (1) | JP2006150214A (en) |
| CN (1) | CN101111765B (en) |
| WO (1) | WO2006057412A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110743517A (en) * | 2018-07-10 | 2020-02-04 | 浙江华谱新创科技有限公司 | Preparation process of polysaccharide derivative coating type chiral stationary phase |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2028487B1 (en) | 2006-05-09 | 2014-01-01 | National University Corporation Nagoya University | Filler for optical isomer separation |
| KR20090049092A (en) | 2006-09-04 | 2009-05-15 | 다이셀 가가꾸 고교 가부시끼가이샤 | Polysaccharide derivative and separating agent for optical isomer containing the same |
| JP5011026B2 (en) * | 2007-08-21 | 2012-08-29 | シャープ株式会社 | SPECIFIC GAS COMPONENT CONCENTRATION DEVICE USING POROUS STRUCTURE AND SPECIFIC GAS COMPONENT DETECTION DEVICE |
| CN101376095B (en) * | 2007-08-28 | 2010-05-26 | 戴新华 | Silica desiccant and its production method |
| WO2009093133A1 (en) * | 2008-01-25 | 2009-07-30 | Medichem, S.A. | Method for determining the enantiomeric purity of indane derivatives |
| EP2239565B1 (en) * | 2008-01-31 | 2014-08-27 | National University Corporation Okayama University | Optical-isomer separating agent for chromatography and process for producing the same |
| JP2011149919A (en) * | 2009-12-25 | 2011-08-04 | Daicel Chemical Industries Ltd | Column for intermediate pressure liquid chromatography, and pre-pack column |
| CN102311504B (en) | 2010-07-09 | 2017-05-10 | 株式会社大赛璐 | polysaccharide derivative and preparation method thereof and separating agent |
| WO2015005361A1 (en) | 2013-07-08 | 2015-01-15 | 国立大学法人京都工芸繊維大学 | Separating agent |
| CN105699559A (en) * | 2016-03-30 | 2016-06-22 | 中国科学院兰州化学物理研究所 | Preparation method of chiral gas chromatographic column taking nano-cellulose or nano-starch derivatives as stationary phase |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6398962B1 (en) * | 1997-06-18 | 2002-06-04 | Merck Kgaa | Use of monolithic sorbents for preparative chromatographic separation |
| US6562744B1 (en) * | 1998-01-23 | 2003-05-13 | Merck Patent Gmbh | Process for producing inorganic porous material in a capillary |
| US20060189796A1 (en) * | 2003-04-24 | 2006-08-24 | Yoshio Okamoto | Separating agent for enantiomeric isomers |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0691956B2 (en) | 1981-03-11 | 1994-11-16 | ダイセル化学工業株式会社 | Adsorbent for separation supporting optically active polymer |
| JPH0713030B2 (en) | 1986-04-02 | 1995-02-15 | エーザイ株式会社 | Separation agent for optical isomers |
| JP3317749B2 (en) * | 1993-01-18 | 2002-08-26 | 直弘 曽我 | Inorganic porous column |
| EP0710219B1 (en) | 1993-07-19 | 1997-12-10 | MERCK PATENT GmbH | Inorganic porous material and process for making same |
| AU691582B2 (en) | 1994-02-25 | 1998-05-21 | Daicel Chemical Industries Ltd. | Process for producing optically active mevalonolactone compound |
| JP2000515627A (en) | 1996-07-19 | 2000-11-21 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Chiral non-particulate solvent |
| DE19726152A1 (en) * | 1997-06-20 | 1998-12-24 | Merck Patent Gmbh | Chiral sorbent for rapid enantiomer separation |
| ES2183236T3 (en) * | 1996-12-26 | 2003-03-16 | Merck Patent Gmbh | PROCEDURE FOR THE PRODUCTION OF INORGANIC MATERIALS. |
| DE19801575A1 (en) * | 1998-01-19 | 1999-07-22 | Merck Patent Gmbh | Preparative chromatographic separation, e.g. of enantiomers |
| DE19726164A1 (en) | 1997-06-20 | 1998-12-24 | Merck Patent Gmbh | Holder for monolithic sorbents |
| JPH11292528A (en) | 1998-01-23 | 1999-10-26 | Naohiro Soga | Production of inorganic porous material |
| JP2002148247A (en) * | 2000-11-09 | 2002-05-22 | Nagoya Industrial Science Research Inst | Separating agent for optical isomer and its manufacturing method |
| AU2003219910A1 (en) * | 2002-02-25 | 2003-09-09 | Cabot Coproration | Compositions comprising continuous networks and monoliths |
-
2004
- 2004-11-29 JP JP2004343683A patent/JP2006150214A/en active Pending
-
2005
- 2005-11-29 EP EP05811734.2A patent/EP1818675B1/en not_active Expired - Lifetime
- 2005-11-29 WO PCT/JP2005/021913 patent/WO2006057412A1/en not_active Ceased
- 2005-11-29 CN CN200580047438.4A patent/CN101111765B/en not_active Expired - Fee Related
-
2007
- 2007-05-29 US US11/806,033 patent/US8883001B2/en active Active
-
2010
- 2010-12-27 US US12/979,031 patent/US8883002B2/en active Active
- 2010-12-27 US US12/979,006 patent/US20110089095A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6398962B1 (en) * | 1997-06-18 | 2002-06-04 | Merck Kgaa | Use of monolithic sorbents for preparative chromatographic separation |
| US6562744B1 (en) * | 1998-01-23 | 2003-05-13 | Merck Patent Gmbh | Process for producing inorganic porous material in a capillary |
| US20060189796A1 (en) * | 2003-04-24 | 2006-08-24 | Yoshio Okamoto | Separating agent for enantiomeric isomers |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110743517A (en) * | 2018-07-10 | 2020-02-04 | 浙江华谱新创科技有限公司 | Preparation process of polysaccharide derivative coating type chiral stationary phase |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101111765B (en) | 2011-02-16 |
| US20070227957A1 (en) | 2007-10-04 |
| US8883002B2 (en) | 2014-11-11 |
| EP1818675A4 (en) | 2008-11-05 |
| US8883001B2 (en) | 2014-11-11 |
| JP2006150214A (en) | 2006-06-15 |
| WO2006057412A1 (en) | 2006-06-01 |
| EP1818675B1 (en) | 2016-01-20 |
| CN101111765A (en) | 2008-01-23 |
| US20110094955A1 (en) | 2011-04-28 |
| EP1818675A1 (en) | 2007-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8883002B2 (en) | Separating agent for optical isomers and separation column for optical isomers | |
| US20080167460A1 (en) | Separating agent for optical isomers, method of production thereof, and separation column for optical isomers | |
| US20070215549A1 (en) | Separating agent for enantiomeric isomers | |
| JP2005315668A (en) | Separating agent for optical isomers | |
| JP3148032B2 (en) | Substituted aromatic carbamate derivatives of polysaccharides and separating agents | |
| JP3635002B2 (en) | Filler for separation of optical isomers for liquid chromatography | |
| US7090775B2 (en) | Separation agent for separating optical isomer and method for preparation thereof | |
| US7740758B2 (en) | Separating agent including polysaccharide derivative having a polycyclic structure | |
| JP2001163806A (en) | Optical isomer separating agent | |
| US20030010696A1 (en) | Separating agent for enantiomeric isomers | |
| JPH0551327A (en) | Optical resolution by polysaccharide derivative | |
| US7683167B2 (en) | Separating agent for enantiomeric isomers | |
| JP3746315B2 (en) | Separating agent | |
| JPH11255671A (en) | Chromatographic separation of optical isomer | |
| JP4430881B2 (en) | Method for producing filler for separation of optical isomers for liquid chromatography | |
| US20060081522A1 (en) | Separating agent for optical isomers | |
| JPH10249191A (en) | Separating agent | |
| JP2013164294A (en) | Polysaccharide derivative and optical isomer separation filler containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |